Merge Labs Investment

Advances in interfaces lead to advances in computing. The more directly users can express their intent, the more powerful and useful technology becomes.

Brain-computer interfaces (BCI) pioneer a new frontier where humans can interact with AI naturally and seamlessly. OpenAI shares this vision and is participating in the seed round of Merge Labs.

Merge Labs is a research lab aiming to combine biological intelligence and artificial intelligence to maximize human capability and experience. They are developing a new approach to BCI that combines biology, devices, and AI to deliver much higher bandwidth while remaining safe.

AI plays a central role throughout Merge Labs' research and development.

• Accelerating research in bioengineering, neuroscience, and device engineering
• Leveraging an AI operating system that interprets user intent, adapts to individuals, and operates reliably even with noisy signals

OpenAI plans to work together with Merge Labs to develop scientific foundation models and other frontier tools, accelerating technological progress.

Merge Labs' co-founders include BCI pioneers Mikhail Shapiro, Tyson Aflalo, and Sumner Norman, with Alex Blania, Sandro Herbig, and Sam Altman participating in a personal capacity.